Feb 26, 2026
David J. Taylor- Amount
- $1,001 to $15,000
- Filed
- Mar 6, 2026
Congress ticker disclosure profile
As of April 2 at 8:00 PM EDT
Public STOCK Act rows mentioning
A factual page for public Congressional disclosures that reference PLD. Veridion shows filed rows, disclosed amount ranges, dates, and source links. It does not imply motive or wrongdoing.
90d rows
0
Feed lifetime
48
Member filers
21
Disclosed ranges
$783K
Most active member desks
27 buys vs 20 sells
Democrat · House · FL-22
Republican · House · OH-2
Democrat · House · CA-18
Republican · House · FL-5
Republican · House · NJ-7
Republican · Senate · LA
Democrat · House · NY-10
Democrat · House · AZ-4
Republican · House · IN-6
Democrat · House · CT-2
Latest trade Mar 20, 2026
Feb 26, 2026
David J. TaylorJan 29, 2026
David J. TaylorJan 16, 2026
David J. TaylorAug 14, 2025
David J. TaylorJun 30, 2025
Thomas H. Kean Jr.Apr 24, 2025
Thomas H. Kean Jr.Apr 7, 2025
Jefferson ShreveOct 24, 2023
Greg StantonSep 28, 2023
Robert J. WittmanSep 8, 2023
Lois FrankelAug 3, 2023
Lois FrankelAug 2, 2023
Lois FrankelJul 14, 2023
Daniel S. GoldmanJul 12, 2023
Lois FrankelMay 25, 2023
Zoe LofgrenMay 3, 2023
Lois FrankelDec 8, 2022
Lois FrankelDec 7, 2022
Lois FrankelNov 30, 2022
Lois FrankelNov 9, 2022
Lois FrankelMar 16, 2022
John H. RutherfordSep 30, 2021
Zoe LofgrenMar 5, 2021
John A. YarmuthNov 5, 2020
Bill CassidyAug 7, 2020
Joe CourtneyMar 23, 2020
Zoe LofgrenSep 25, 2018
John H. Rutherford| Date | Member | Action | Amount | Filed | Receipt |
|---|---|---|---|---|---|
| Feb 26, 2026 | David J. Taylor | Sell | $1,001 to $15,000 | Mar 6, 2026 | Open card |
| Jan 29, 2026 | David J. Taylor | Buy | $1,001 to $15,000 | Feb 2, 2026 | Open card |
| Jan 16, 2026 | David J. Taylor | Sell | $1,001 to $15,000 | Feb 2, 2026 | Open card |
| Aug 14, 2025 | David J. Taylor | Buy | $1,001 to $15,000 | Sep 2, 2025 | Open card |
| Jun 30, 2025 | Thomas H. Kean Jr. | Buy | $1,001 to $15,000 | Jul 16, 2025 | Open card |
| Apr 24, 2025 | Thomas H. Kean Jr. | Buy | $1,001 to $15,000 | May 15, 2025 | Open card |
| Apr 7, 2025 | Jefferson Shreve | Sell | $15,001 to $50,000 | May 8, 2025 | Open card |
| Oct 24, 2023 | Greg Stanton | Sell | $1,001 to $15,000 | Nov 9, 2023 | Open card |
| Sep 28, 2023 | Robert J. Wittman | Sell | $1,001 to $15,000 | Oct 19, 2023 | Open card |
| Sep 8, 2023 | Lois Frankel | Sell | $15,001 to $50,000 | Oct 10, 2023 | Open card |
| Aug 3, 2023 | Lois Frankel | Buy | $1,001 to $15,000 | Aug 26, 2023 | Open card |
| Aug 2, 2023 | Lois Frankel | Buy | $1,001 to $15,000 | Aug 26, 2023 | Open card |
| Jul 14, 2023 | Daniel S. Goldman | Sell | $1,001 to $15,000 | Aug 13, 2023 | Open card |
| Jul 12, 2023 | Lois Frankel | Buy | $1,001 to $15,000 | Jul 28, 2023 | Open card |
| May 25, 2023 | Zoe Lofgren | Sell | $1,001 to $15,000 | Jun 6, 2023 | Open card |
| May 3, 2023 | Lois Frankel | Buy | $1,001 to $15,000 | May 19, 2023 | Open card |
| Dec 8, 2022 | Lois Frankel | Buy | $1,001 to $15,000 | Jan 6, 2023 | Open card |
| Dec 7, 2022 | Lois Frankel | Buy | $1,001 to $15,000 | Jan 6, 2023 | Open card |
| Nov 30, 2022 | Lois Frankel | Buy | $1,001 to $15,000 | Jan 6, 2023 | Open card |
| Nov 9, 2022 | Lois Frankel | Buy | $1,001 to $15,000 | Nov 18, 2022 | Open card |
| Mar 16, 2022 | John H. Rutherford | Sell | $1,001 to $15,000 | Apr 19, 2022 | Open card |
| Sep 30, 2021 | Zoe Lofgren | Buy | $1,001 to $15,000 | Oct 7, 2021 | Open card |
| Mar 5, 2021 | John A. Yarmuth | Buy | $1,001 to $15,000 | Apr 21, 2021 | Open card |
| Nov 5, 2020 | Bill Cassidy | Sell | $1,001 to $15,000 | Dec 8, 2020 | Open card |
| Aug 7, 2020 | Joe Courtney | Sell | $1,001 to $15,000 | Aug 27, 2020 | Open card |
| Mar 23, 2020 | Zoe Lofgren | Sell | $1,001 to $15,000 | Apr 11, 2020 | Open card |
| Sep 25, 2018 | John H. Rutherford | Sell | $1,001 to $15,000 | Oct 2, 2018 | Open card |
Source creed
This page is assembled from public STOCK Act disclosure records in the Veridion warehouse. 48 of 48 filed rows include disclosed amount ranges (100%). Rows without ranges stay labeled. Identification only; it does not imply motive or wrongdoing.
Disclosure findings, methodology notes, and product updates when we have them. No fixed schedule yet. No advertising list resale.